Research keywords (3):
GPCR
, Neuroimmunology
, Immunology
Research theme for competitive and other funds (3):
2022 - 2025 The molecular mechanism of the crosstalk between the beta-2 adrenergic receptor and chemokine receptors in lymphocytes
2019 - 2022 新たなGPCRシグナル伝達制御因子の機能阻害剤の探索
2016 - 2019 走化性因子受容体の新たな制御因子の機能とその免疫系における役割
Papers (11):
Taiichiro Shirai, Akiko Nakai, Kazuhiro Suzuki. Chemoattractant receptor signaling in humoral immunity. International Immunology. 2024
Noam Ben-Shalom, Elad Sandbank, Lilach Abramovitz, Hadas Hezroni, Talia Levin, Estherina Trachtenberg, Nadav Fogel, Michael Mor, Ron Yefet, Liat Stoler-Barak, et al. β2-Adrenergic Signaling Promotes Higher-Affinity B Cells and Antibodies. Brain, behavior, and immunity. 2023
Taiichiro Shirai, Akiko Nakai, Emiko Ando, Jun Fujimoto, Sarah Leach, Takao Arimori, Daisuke Higo, Floris J. van Eerden, Janyerkye Tulyeu, Yu-Chen Liu, et al. Celastrol suppresses humoral immune responses and autoimmunity by targeting the COMMD3/8 complex. Science Immunology. 2023. 8. 81
Akiko Nakai, Sarah Leach, Kazuhiro Suzuki. Control of immune cell trafficking through inter-organ communication. International Immunology. 2021. 33. 6. 327-335
Akiko Nakai, Jun Fujimoto, Haruhiko Miyata, Ralf Stumm, Masashi Narazaki, Stefan Schulz, Yoshihiro Baba, Atsushi Kumanogoh, Kazuhiro Suzuki. The COMMD3/8 complex determines GRK6 specificity for chemoattractant receptors. The Journal of experimental medicine. 2019. 216. 7. 1630-1647